Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2020 Filed Sep 23, 2020 16:21 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Unit · Derivative | 154.7892 | $161.51 | $25,000.00 |
DisclosureSEC source: 0001555280-20-000280 · wf-form4_160089249626566.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,232.9114 Underlying: Common Stock · 154.7892 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 16:18 UTC |
Rhodes LindaDirector
|
SaleCommon Stock | 1,087 | $159.16 | $173,006.92 |
DisclosureSEC source: 0001555280-20-000273 · wf-form4_159959628473330.xml · nonDerivative · entry 1 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:48 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,407 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 3,538 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:48 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 1,179 | $160.71 | $189,477.09 |
DisclosureSEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,335 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:48 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 1,179 | $41.83 | $49,317.57 |
DisclosureSEC source: 0001555280-20-000271 · wf-form4_159907967840830.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,685 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 6,500 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 69,536 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 5,699 | $157.86 | $899,644.14 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.64 to $157.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,801 | $157.31 | $755,245.31 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,573 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.64 to $157.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:00 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,500 | $30.89 | $200,785.00 |
DisclosureSEC source: 0001555280-20-000269 · wf-form4_159847922575221.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:27 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,598 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 13,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:27 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 6,000 | $160.37 | $962,220.00 |
DisclosureSEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,680 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.04 to $161.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:27 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 6,000 | $41.83 | $250,980.00 |
DisclosureSEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 16:23 UTC |
Reed Willie MDirector
|
SaleCommon Stock | 1,885 | $159.07 | $299,846.95 |
DisclosureSEC source: 0001555280-20-000264 · wf-form4_159769579155510.xml · nonDerivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,635 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:26 UTC |
Knupp Catherine A.Executive Vice President
|
SaleCommon Stock | 3,000 | $159.52 | $478,560.00 |
DisclosureSEC source: 0001555280-20-000265 · wf-form4_159769598579511.xml · nonDerivative · entry 2 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,368 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.13 to $159.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:26 UTC |
Knupp Catherine A.Executive Vice President
|
SaleCommon Stock | 10,000 | $158.66 | $1,586,600.00 |
DisclosureSEC source: 0001555280-20-000265 · wf-form4_159769598579511.xml · nonDerivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,368 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.12 to $159.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 17:32 UTC |
Rhodes LindaDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,270.0727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · derivative · entry 3 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,023.2396 Underlying: Common Stock · 3,270.0727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,270.0727 RSUs vested on August 3, 2020; 2,771.4602 RSUs will vest on February 13, 2021; 2,651.1276 RSUs will vest on February 12, 2022; and 1,600.6518 RSUs will vest on February 11, 2023. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 17:32 UTC |
Rhodes LindaDirector
|
OtherCommon Stock | 720 | $154.51 | $111,247.20 |
DisclosureSEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · nonDerivative · entry 2 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,555 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 17:32 UTC |
Rhodes LindaDirector
|
Exercise / conversionCommon Stock | 3,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000251 · wf-form4_159657644567811.xml · nonDerivative · entry 1 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:31 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,586 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 4,717 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:31 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 1,179 | $152.19 | $179,432.01 |
DisclosureSEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,335 Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:31 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 1,179 | $41.83 | $49,317.57 |
DisclosureSEC source: 0001555280-20-000249 · wf-form4_159657299079765.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:32 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantPhantom Stock Unit · Derivative | 327.0981 | $45.27 | $14,807.73 |
DisclosureSEC source: 0001555280-20-000237 · wf-form4_159536351623390.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,044.0586 Underlying: Common Stock · 102.3623 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 22:53 UTC |
McFarland James MichaelExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 32.9362 | $45.27 | $1,491.02 |
DisclosureSEC source: 0001555280-20-000246 · wf-form4_159537196219303.xml · derivative · entry 1 McFarland James Michael · CIK 0001801162 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,412.9231 Underlying: Common Stock · 10.3071 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F3 · balance_after: Includes 69.6 phantom stock units inadvertently omitted from the reporting person's Form 4 filed on April 2, 2020. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:51 UTC |
Bettington Timothy JExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 156.1153 | $45.27 | $7,067.34 |
DisclosureSEC source: 0001555280-20-000244 · wf-form4_159536466499393.xml · derivative · entry 1 Bettington Timothy J · CIK 0001797894 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259.8523 Underlying: Common Stock · 48.8548 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:48 UTC |
Knupp Catherine A.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 211.1272 | $45.27 | $9,557.73 |
DisclosureSEC source: 0001555280-20-000243 · wf-form4_159536452469709.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,267.7892 Underlying: Common Stock · 66.0703 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:46 UTC |
Mamilli WafaaExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 178.4173 | $45.27 | $8,076.95 |
DisclosureSEC source: 0001555280-20-000242 · wf-form4_159536437778152.xml · derivative · entry 1 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518.5943 Underlying: Common Stock · 55.834 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:43 UTC |
Chen Heidi C.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 182.8783 | $45.27 | $8,278.90 |
DisclosureSEC source: 0001555280-20-000241 · wf-form4_159536421093476.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,360.4307 Underlying: Common Stock · 57.2301 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:41 UTC |
Kelly Robert EdwardExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 156.1153 | $45.27 | $7,067.34 |
DisclosureSEC source: 0001555280-20-000240 · wf-form4_159536405431970.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,113.7003 Underlying: Common Stock · 48.8548 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:35 UTC |
David GlennChief Financial Officer
|
GrantPhantom Stock Unit · Derivative | 215.5882 | $45.27 | $9,759.68 |
DisclosureSEC source: 0001555280-20-000238 · wf-form4_159536373087975.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,056.8293 Underlying: Common Stock · 67.4663 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:38 UTC |
Alaix Juan RamonDirector
|
GrantPhantom Stock Unit · Derivative | 61.1716 | $45.27 | $2,769.24 |
DisclosureSEC source: 0001555280-20-000239 · wf-form4_159536389884395.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,083.6325 Underlying: Common Stock · 19.1431 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:29 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 166.5233 | $45.27 | $7,538.51 |
DisclosureSEC source: 0001555280-20-000236 · wf-form4_159536337559576.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,601.6293 Underlying: Common Stock · 52.1119 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 4,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,577 Underlying: Common Stock · 4,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 4,080 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC |
Trawicki RomanExecutive Vice President
|
SaleCommon Stock | 5,499 | $137.29 | $754,957.71 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,421 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionCommon Stock | 4,079 | $55.02 | $224,426.58 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:13 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,765 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 5,896 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:13 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 1,179 | $137.29 | $161,864.91 |
DisclosureSEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,335 Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:13 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 1,179 | $41.83 | $49,317.57 |
DisclosureSEC source: 0001555280-20-000225 · wf-form4_159372797108332.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 16:25 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Unit · Derivative | 181.0151 | $138.11 | $25,000.00 |
DisclosureSEC source: 0001555280-20-000218 · wf-form4_159303028870709.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,057.3047 Underlying: Common Stock · 181.0151 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:18 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,944 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,075 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:18 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 1,179 | $138.65 | $163,468.35 |
DisclosureSEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,335 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:18 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 1,179 | $41.83 | $49,317.57 |
DisclosureSEC source: 0001555280-20-000216 · wf-form4_159112910980681.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,185 Underlying: Common Stock · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 3,885 options granted January 31, 2013 at an exercise price of $26.00 per option and 2,615 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 76,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,800 | $131.65 | $368,620.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.46 to $131.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 7,700 | $131.19 | $1,010,163.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,674 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.43 to $131.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,615 | $30.89 | $80,777.35 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:29 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,885 | $26.00 | $101,010.00 |
DisclosureSEC source: 0001555280-20-000211 · wf-form4_159069776425377.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:19 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 4,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,598 Underlying: Common Stock · 4,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:19 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 4,463 | $131.02 | $584,742.26 |
DisclosureSEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,680 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.39 to $131.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:19 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 4,463 | $46.09 | $205,699.67 |
DisclosureSEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019. Read SEC document |
| May 01, 2020 Filed May 4, 2020 20:49 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000192 · wf-form4_158862533753154.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,123 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 1,179 options granted February 19, 2016 at an exercise price of $41.83 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 8,254 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.